Articles

Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab

University Children’s Hospital, Department of Pediatric Hematology and Oncology, University of Tuebingen
University Children’s Hospital, Department of Pediatric Hematology and Oncology, University of Tuebingen
Amgen Research Munich GmbH
University Children’s Hospital, Department of Pediatric Hematology and Oncology, University of Tuebingen
University Children’s Hospital, Department of Pediatric Hematology and Oncology, University of Frankfurt, Germany
University Children’s Hospital, Department of Pediatric Hematology and Oncology, University of Tuebingen
University Children’s Hospital, Department of Pediatric Hematology and Oncology, University of Tuebingen
University Children’s Hospital, Department of Pediatric Hematology and Oncology, University of Tuebingen
University Children’s Hospital, Department of Pediatric Hematology and Oncology, University of Tuebingen
University Children’s Hospital, Department of Pediatric Hematology and Oncology, University of Tuebingen
University Children’s Hospital, Department of Pediatric Hematology and Oncology, University of Tuebingen
University Children’s Hospital, Department of Pediatric Hematology and Oncology, University of Tuebingen
Vol. 99 No. 7 (2014): July, 2014 https://doi.org/10.3324/haematol.2013.100073